These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 22722789
1. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma. Ishiguro F, Murakami H, Mizuno T, Fujii M, Kondo Y, Usami N, Yokoi K, Osada H, Sekido Y. J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789 [Abstract] [Full Text] [Related]
2. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer. Ishiguro F, Murakami H, Mizuno T, Fujii M, Kondo Y, Usami N, Taniguchi T, Yokoi K, Osada H, Sekido Y. J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775 [Abstract] [Full Text] [Related]
3. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. Ikeda K, Quertermous T. J Biol Chem; 2004 Dec 31; 279(53):55315-23. PubMed ID: 15496415 [Abstract] [Full Text] [Related]
4. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. Kijima N, Hosen N, Kagawa N, Hashimoto N, Nakano A, Fujimoto Y, Kinoshita M, Sugiyama H, Yoshimine T. Neuro Oncol; 2012 Oct 31; 14(10):1254-64. PubMed ID: 22166264 [Abstract] [Full Text] [Related]
5. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma. Greillier L, Tounsi A, Berenguer-Daizé C, Dussault N, Delfino C, Benyahia Z, Cayol M, Mabrouk K, Garcia S, Martin PM, Barlesi F, Ouafik L. J Thorac Oncol; 2016 Jan 31; 11(1):94-107. PubMed ID: 26762744 [Abstract] [Full Text] [Related]
6. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation. Ye M, Du YL, Nie YQ, Zhou ZW, Cao J, Li YF. Mol Med Rep; 2015 Mar 31; 11(3):2004-12. PubMed ID: 25395097 [Abstract] [Full Text] [Related]
7. Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS. Clin Cancer Res; 2012 Jan 01; 18(1):77-90. PubMed ID: 22028491 [Abstract] [Full Text] [Related]
8. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. Servais EL, Colovos C, Rodriguez L, Bograd AJ, Nitadori J, Sima C, Rusch VW, Sadelain M, Adusumilli PS. Clin Cancer Res; 2012 May 01; 18(9):2478-89. PubMed ID: 22371455 [Abstract] [Full Text] [Related]
9. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. Sudo H, Tsuji AB, Sugyo A, Abe M, Hino O, Saga T. Int J Oncol; 2014 Feb 01; 44(2):530-8. PubMed ID: 24253341 [Abstract] [Full Text] [Related]
10. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma. Cheng YY, Kirschner MB, Cheng NC, Gattani S, Klebe S, Edelman JJ, Vallely MP, McCaughan BC, Jin HC, van Zandwijk N, Reid G. J Thorac Oncol; 2013 Oct 01; 8(10):1317-28. PubMed ID: 24457242 [Abstract] [Full Text] [Related]
11. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule. van Kilsdonk JW, Wilting RH, Bergers M, van Muijen GN, Schalkwijk J, van Kempen LC, Swart GW. Cancer Res; 2008 May 15; 68(10):3671-9. PubMed ID: 18483249 [Abstract] [Full Text] [Related]
12. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia. Alì G, Borrelli N, Riccardo G, Proietti A, Pelliccioni S, Niccoli C, Boldrini L, Lucchi M, Mussi A, Fontanini G. J Thorac Oncol; 2013 Nov 15; 8(11):1389-95. PubMed ID: 24084442 [Abstract] [Full Text] [Related]
13. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma. van Kilsdonk JW, Takahashi N, Weidle U, Burtscher H, Jarry J, Daha MR, Swart GW, van Kempen LC. J Invest Dermatol; 2012 May 15; 132(5):1462-70. PubMed ID: 22318386 [Abstract] [Full Text] [Related]
14. MicroRNAs dysregulation in human malignant pleural mesothelioma. Balatti V, Maniero S, Ferracin M, Veronese A, Negrini M, Ferrocci G, Martini F, Tognon MG. J Thorac Oncol; 2011 May 15; 6(5):844-51. PubMed ID: 21358347 [Abstract] [Full Text] [Related]
15. Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma. Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M. Hum Pathol; 2018 Jan 15; 71():1-7. PubMed ID: 28811252 [Abstract] [Full Text] [Related]
18. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Butnor KJ, Pass HI, Carbone M, Testa JR, Heintz NH, Mossman BT. Int J Cancer; 2011 Sep 01; 129(5):1075-86. PubMed ID: 21710492 [Abstract] [Full Text] [Related]
19. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy. Hoda MA, Mohamed A, Ghanim B, Filipits M, Hegedus B, Tamura M, Berta J, Kubista B, Dome B, Grusch M, Setinek U, Micksche M, Klepetko W, Berger W. J Thorac Oncol; 2011 May 01; 6(5):852-63. PubMed ID: 21358348 [Abstract] [Full Text] [Related]
20. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Degen WG, van Kempen LC, Gijzen EG, van Groningen JJ, van Kooyk Y, Bloemers HP, Swart GW. Am J Pathol; 1998 Mar 01; 152(3):805-13. PubMed ID: 9502422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]